Turner Syndrome Market 2020 Analysis, Industry Size, Share Leaders, Current Status by Major vendors and Trends by Forecast to 2027

 Turner Syndrome is a rare chromosomal condition diagnosed in the female population. It occurs when one of the X chromosome is partially or completely missing. Women with condition are shorter than the average female and are unable to conceive due to early loss of the ovarian function. Webbed neck, a low hairline at the neck’s back, lymphedema are some of the common symptoms of the disease. Increasing prevalence of the disease and rising female population are the major factors that drives the market during the forecast period. According to the National Library of Medicine in 2017, about 1 in 2,500 new-born girls, worldwide, were affected with the Turner Syndrome, making it one of the causes of female-fetal-miscarriages and stillbirths. Moreover, according to the World Bank the female population increased from 3.60 billion in 2014 to 3.68 billion in 2016. Additionally, the increasing FDA approvals for the treatment of the diseases followed by growing biotechnology sector and increasing awareness of the women health is expected to fuel the market growth. However, high annual treatment cost followed by its related side effects like vomiting, carpal tunnel syndrome, insulin resistance/ high blood sugar, worsening of scoliosis, and others is one of the major restrains for the market growth. This along with low per capita healthcare expenditure and lack of the awareness within the low and middle income countries is projected to restrain the market growth during the forecast period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5160

The market for global turner syndrome is estimated to grow at an approximate CAGR of 13.0% from 2017 to 2023.

Segmentation

The global turner syndrome market is segmented on the basis of diagnosis, treatment, and end user.

On the basis of the diagnosis, the market is categorised into physical examination, prenatal testing, karyotyping and others. The prenatal testing segment, by diagnosis, is sub-segmented into ultrasound test, amniocentesis, chorionic villus sampling, and others.

On the basis of the treatment, the market is segmented into human growth hormone therapy, oestrogen replacement therapy, progesterone replacement therapy, psychological therapy, and others.

On the basis of the end user, the market is segmented into hospitals & clinics, academic institutes, research organization, and others.

Regional Analysis

America dominates the global turner syndrome market owing to increasing adoption of new technologies and huge patient population. Additionally, rising healthcare expenditure, increasing female population followed by the presence of developed economies and healthcare sector within the region fuels the market growth.

Europe is the second largest market, in the global turner syndrome market. Rising research and development in healthcare sector, huge patient population, growing biotechnology sector are the major drivers for the market growth within the region. According to the International Trade Administration, the total turnover for the biotechnology sector in Germany reached from USD 3,280 million in 2015 to USD 3,410 million in 2016. It was also estimated that in 2016, the R&D expenditure for biotech sector was about USD 1,040 million

Asia Pacific region is the fastest growing market. Increasing awareness for women health, rising healthcare expenditures and growing healthcare sector are the major drivers for the market growth within the region during the forecast period. Moreover, the presence of the developing countries like the India and China within the region fuels the market growth. According to the Indian Brand Equity Foundation in 2017, the Indian healthcare sector was one of the fastest growing industries in India and is expected to advance at a CAGR of 22.87% from 2015-2020.

The Middle East & Africa has the least share in the global turner syndrome market.  The presence of poor economies and stringent government policies, especially in the African region restrains the market growth within the region. Majority of the market in the Middle & Africa region is held by the Middle East due to a well-developed healthcare sector and huge healthcare expenditure by the presence of the developed economies like Saudi Arabia, Kuwait, and Qatar within the region.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/turner-syndrome-market-5160

Throat Cancer Market: Information, Figures and Analytical Insights 2020-2027

 Cancer is a condition with uncontrolled division of cells spreading unusually in the body. These abnormal cells accumulate at a specific site to form mass of cells called tumors. Throat cancer refers to tumor of the voice box, the vocal cords, and different parts of the throat, for example, the tonsils and the oropharynx. The throat cancer is categorized into two types: pharyngeal cancer and laryngeal cancer.

The throat cancer market is growing at a fast pace and is expected to growth in the near future. The major factors that driving the growth of this market are the increasing geriatric population, increasing rate of cancer survival, changing lifestyle, high number of tobacco consumers, and increasing smoking population. The treatment procedure for the throat cancer is becoming more effective with increasing success rates. The increasing demand for these treatments will grow resulting in the growth of the global throat cancer market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1792 

There are emerging new drugs, therapies for the treatment and occurrence of throat cancer, the ever increasing demand and popularity of these treatments will grow eventually. Globally around 157,000 new cases of laryngeal cancer were diagnosed in 2012. According to National Cancer Institute (NIH), about 1.1% of adult population is estimated to be diagnosed with pharyngeal cancer followed by 0.4% with laryngeal cancers at some point during their lifetime.

With the increasing prevalence of throat cancer, raise in HPV infections, alcohol consumption and rising aging population are the major factors driving the growth of throat cancer market in the forecast period. According to American Cancer Society (ACS), around 13,430 new cases of laryngeal cancer were diagnosed among them 79% were men and 21% were women in 2016. Throat cancer are more common in men than women that are probably because of their smoking habits.

Combination therapy are more preferred for the treatment of throat cancer die to different mechanisms and the combined ability to decrease the resistance of the cancer cells to drugs. Cisplatin and 5-FU are more commonly used chemotherapy drugs to treat the throat cancers but these drugs have numerous side effects such as diarrhoea, kidney damage and heart problems. The global throat cancer market has been examined as a swiftly growing market and expected to grow at a tremendous rate.

Ongoing research to develop the newer chemotherapies such as targeted therapies by using EGFR inhibitors and angiogenesis inhibitors to treat the throat cancer. The recent use of transoral robotic surgeries are gaining traction for the physicians to remove the tumors due to minimal invasion to conduct the surgery in a precise manner with fewer side effects. In the case of the radiation therapy, few doctors are trying to kill the cancer cells by using proton beam therapy because these cause less damage to the tissues they pass through than the X-rays.

However, lack of target specific drugs to treat the throat cancer, side effects of the chemotherapy drugs and lack of diagnosis of the disease are some of the factors that may hamper the growth of throat cancer treatment market in near future.

Global Throat Cancer Market – Regional:

Geographically, the regional market is segmented into America, Europe, Asia Pacific, and the Middle East & Africa.

The North America dominated the global throat cancer market with the U.S. holding the largest market share. The factors that drive the throat cancer market are the rising aging population, growing demand for advanced cancer therapies, increasing government funding in the healthcare sector, and growth of cancer care facilities in emerging countries

In Europe, due to increase in the incidence of throat cancer because of increase in smoking, tobacco and alcohol consumption in these regions. Cancer of the larynx is uncommon in the UK with around 2,000 cases developing each year. It is four times more common in men than in women. It is rare in people aged under 40 years and is most common in people aged over 60 years.

Asia Pacific region is expected to grow rapidly with developing countries such as China and India leading this market due to the fast growing healthcare sector and large unmet needs over the forecast period.

The Middle East & African market especially, the African region is expected to witness a poor growth owing to the lack of knowledge in medical sector, and less development in medical facilities in Middle East & Africa will have limited growth in the market.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/throat-cancer-market-1792 

 
About Us:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Capnography Market Insights Analysis 2020-2027

 The global capnography market is expected to grow during the forecast period from 2018 to 2027 at a CAGR of ~19.5%. Capnography is the process used to measure and determine the concentration of Carbon Dioxide (CO2) in respiratory gases by using the capnograph device. It helps to measure the actual concentration of carbon dioxide in the bloodstream. The capnograph is used to monitor the inhaled and exhaled concentration of CO2. The growing pediatric population, increasing number of patients suffering from cardiac diseases, and increasing aging population are expected to drive the growth of the market. The global capnography market is estimated to grow during the forecast period due to factors such as innovation, technological advancements, and advancement of the capnography device. A strong recommendation about capnography was made by healthcare bodies such as the American Society of Anesthesiologists, European Resuscitation Council, and others to include capnography devices in healthcare facilities compulsorily. This fuels the growth of the global capnography market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1535 

Segmentation

The global capnography market is segmented on the basis of type, devices, application, and end-user.  The global capnography market on the basis of type is segmented into capnograph and disposable.  Capnograph is further subdivided into three segments, namely, mainstream capnography, sidestream capnography, and micro stream capnography. Mainstream capnography is further subdivided sand alone monitor, handheld monitor, and multi-parameter monitor. Based on device, the global capnography market is segmented into handheld monitors, stand-alone monitors, and others. Based on application the global capnography market is segmented into procedural sedation, critical care, emergency medicine, pain management, and general floor. Based on end-user the global capnography market is segmented into hospitals, clinics, and ambulatory surgical centers.

Key players

Smiths Medical Inc, Nonin medical Inc, Dreagerwerk AG & CO. KGaA, Welch Allyn, Medtronic, Masimo, Nihon Kohden Corporation, Care fusion cooperation, Covidien Ltd, Diamedica Limited, Edan Instruments, Inc., Hill Rom Holding Inc, Koninklijke Philips N.V., and BD

Regional Market Summary

Based on region, the global capnography research market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.

The Americas is sub-segmented into North America and South America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the UK, Spain, and the rest of Western Europe. The Asia-Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia-Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.

The American market is likely to dominate the global capnography market owing to the rising prevalence of chronic diseases in the aging population and the growing occurrence of asthma in pediatrics. North America dominates the global capnography market due to the development of advanced products in this region. Latin America is showing significant growth in the capnography market due to increasing use of capnography devices in healthcare facilities as recommended by government bodies. The World Health Organization has published a report on Safe Surgery that recommended the use of capnography monitoring devices during the endotracheal tube placement surgery. The American Society of Anesthesiologists also recommended the use of capnography during procedural sedation and anesthesia. The rising problems of respiratory diseases because of an unhealthy lifestyle and high-stress level impact have led to significant growth in this market.

The European market is the second largest in the global capnography market. The market growth in this region is due to government funding and support from the healthcare sector. However, growing number of surgeries and changing lifestyle have contributed to the growth of the market in this region.

Asia-Pacific is anticipated to be the fastest growing market owing to the increasing aging population and rising prevalence of diseases. The capnography market in Asia-Pacific is anticipated to grow during the forecast period due to rising healthcare expenditure and increasing awareness about the capnography technique.

Countries such as India and China are more focused on the global capnography market because of the growing purchasing power and the increasing population as compared to other developing countries.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/capnography-market-1535 

 
About Us:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Medical Holography Market Current Trends, SWOT Analysis, Strategies, Industry Challenges, Business Overview and Forecast Research Study 2027

 A holography is a method of producing a three-dimensional image of an object using an interference pattern. The existing 3D technologies such as 3D-CT, 3D rotational angiography, 3D-ultrasound revolutionized medicine because they allowed doctors to see an individual patient's anatomy without cutting into the body. The exceptional penetration rate of holography products is attributable to the natural benefits of this technology over conservative alternatives, which influence companies to work further toward developing these products for subsequent commercialization.

The global medical holography market is majorly driven by factors such as rapid adoption of holography technology by medical fraternity for applications such as medical education, dentistry, orthopedics, increasing applications of holography in diagnostic imaging to visualize complex 3D structures in human body and biomedical research recent technological advancements in holography products are expected to significantly contribute to the growth of the market throughout the forecast period. 

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1519 

Technological advances in hologram recording techniques in the recent years and the availability of tools for interpretation of holographic interferograms should boost its usage in the field of urology, pathology, ophthalmology, and orthopedics. Moreover, endoscopic holography should emerge as a powerful tool for non-contact high resolution and non-invasive measurements inside the human organs.

The market for Medical holography will grow very rapidly at a rate of 32% CAGR during the forecasted period 2017-2023. The market is expected to reach USD 3.5 billion during the forecasted period.

Industry updates:

Nov, 2016 Holoxica Limited introduced a holographic 3D digital human anatomy atlas prototype for neuroscience. This product impacted medical science giving neurosurgeons and clinicians insights into identifying, diagnosing and treating a wide range of neurological conditions.

Dec, 2015 Japan scientists developed touchable holograms, which are to be adopted in wide range of applications in the future, to enable improved demonstration of biological processes and procedures.

Nov, 2015 Zebra Imaging acquired Rattan, a software-consulting firm. This acquisition was carried out to accelerate the integration of advanced 3D light-field technology in their array of holographic display products.

Dec, 2014 Bristol University developed a touchable holographic display through the generation of air disturbances using ultrasound to create 3D haptic shapes.

Oct, 2014 Zebra Imaging entered into a partnership with Zygote Media Group to develop advanced 3D biomedical models to visualize human anatomy.

Oct, 2013 RealView Imaging Ltd. and Royal Philips completed an assessment of live 3D holographic imaging, which facilitates 3D interaction and facilitates minimally-invasive structural heart disease procedures.

Sept, 2012 Zebra Imaging, Inc.’s digital print technologies have proven useful in medical, military, retail, and other commercial disciplines. This acquisition will add new products to HoloTech AG’s product portfolio, which will also help the company to expand its presence in holographic digital print operations.

Global Medical holography Market – Regional:

Geographically, the regional market is segmented into America, Europe, Asia Pacific, and the Middle East & Africa.

America accounts the larger market for the hologram machines. As the early adoption of new technologies and more R&D is being carried out in this region. North America is the largest market for the hologram machines which is led by the United States. The adoption of new technology is more in this region as the research and development is also more and developing day by day.

Europe is the second largest market as it also has the advanced technologies and its own R&D. The region is also having its own set of regulations for the medical regulations. The expenditures are also more by the government bodies for the healthcare and adoption for the new and sophisticated technologies.

The Asia-Pacific region is witnessing fast growth in this region because of the rising factors such as healthcare spending, improving healthcare infrastructure in developing economies such as China, India, and South Korea, and growing awareness regarding the usage of holography products in medical applications.

The Middle East and Africa region is growing slowly due to factors like large number of unskilled labours, illiteracy is more, and economic development is slow.

Real View Imaging (Israel), Echo Pixel (CA), Integraf (USA), Royal Philips (Netherland), Zebra imaging, Eon Reality (US), Nano live SA (Switzerland), Holoxcia (Engalnd), Lyncee Tec (Switzerland), Mach 7 Technologies, General Electric Company, DPL Industri A/S Denmark, Olomagic, Arnold Herzig GmbH and others are some of the prominent players at the forefront of competition in the global medical holography treatment market and are profiled in MRFR Analysis.  

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/medical-holography-market-1519 

Cervical Dystonia Market Foraying into Emerging Economies 2020-2027

 Cervical dystonia is a rare disease also known as spasmodic torticollis. It is one of the painful chronic neurological movement disorder causing the neck to turn involuntary to any of the direction. It is a rare disease. The major driving factors for the market for cervical dystonia is increasing aging population across the globe. Females are more likely to be get affected by cervical dystonia. Beside this increasing number of treatment for cervical Dystonia and improvement in infrastructure has provided fuel for the growth of the market. On other hand success rate of the treatment and increasing cost of the treatment is the major cause for restraining the growth of cervical Dystonia market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1416 

Global cervical dystonia market is expected to grow at a CAGR of 5% during forecasted period 2017-2023.

Segmentation

Global cervical dystonia market has been segmented on the basis of type which includes torticollis, retrocollis, laterocollis and others.  On the basis of treatment they are segmented into oral therapy, intravenous, surgery and other. On the basis of end user they are segmented into hospital, clinics and other.

Regional Analysis

On regional basis, global cervical dystonia market is dominated by North America which is followed by Europe. Increasing prevalence of cervical dystonia and increasing aging population is the major factor for growth of this market in this region. Asia Pacific is the fastest growing region for the cervical dystonia market. While due to less development in pharmaceutical and medical sector Middle East and Africa contribute least in cervical dystonia market.

Key players for global cervical dystonia market

ALLERGAN (Ireland), Solstice Neurosciences LLC, Ipsen Biopharmaceuticals Inc. (France), Merz Inc (US), Addex Therapeutics (Switzerland) Revance Therapeutics Inc. (US) and many other.

The report for global cervical dystonia market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/cervical-dystonia-market-1416 

Surgical Instrument Tracking System Market Foraying into Emerging Economies 2020-2027

 Global Surgical Instrument Tracking System Market was valued at USD 186.85 Million in 2019 and is expected to register a CAGR of 15.07% during the forecast period of 2020 to 2027.

Surgical instrument tracking systems are systems that can combine scanning technology and application software. They help healthcare professionals to access time-saving tools, leading to them performing efficient and time-saving procedures. The surgical tracking systems are very much useful in organizing surgical sets, usage cycle tracking, and documentation of instruments used, understanding the replacement of instruments, and other applications.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1391 

Factors that drive the market growth are the high rate of adoption of the surgical instrument tracking systems by hospitals, the need to meet unique device identification mandates, the convenience provided by surgical instrument tracking system in the management of inventories, and the increasing number of surgical instruments used in various surgeries. However, the high cost of implementing automated tracking systems coupled with a fall in the number of surgeries due to a pandemic is hampering the growth of the market.

Previously, it was only used for instrument count sheet management along with a few basic tasks such as traceability of instruments. The 2D barcodes have helped sterile handling and identification of instruments and help in tracking the history of each instrument’s use. Major healthcare providers are signing long-term agreements with surgical instrument tracking system suppliers for improving the quality of the inventory management systems. For instance, recently, Universal Health Services, Inc., one of the hospital management companies, which have a large network of hospitals in the US, signed a multi-year contract with Censis Technologies, Inc. for its surgical instrument tracking system Censitrac.

Market Dynamics

The surgical instrument tracking systems are used in the healthcare facilities to streamline the workflow, regulate the costs, and reduce waste as well as for effective inventory management. There are several benefits of surgical instrument tracking systems. Key players operating in the surgical instrument tracking system market are engaged in the acquisition of companies with similar products to expand their product portfolio and maintain a global footprint. For instance, in October 2019, Fortive Corporation (US) acquired Censis Technologies, Inc. (US). This acquisition helped Fortive Corporation to add a surgical instrument tracking systems product portfolio.

The growth of the global surgical instrument tracking system market can be attributed to the high rate of adoption of the surgical instrument tracking systems by hospitals, technological advancements in the surgical instrument tracking system market, and the growing number of surgical procedures globally. Technological advancements in the surgical instrument tracking system segment are reducing the time required for the process and increasing the accessibility and efficiency of inventory management in the medical facilities. It is also providing real-time data collection and monitoring of surgical instruments used in the healthcare facility. The market players have been engaged in the development of innovative products and services for catering to the needs of the healthcare providers. For instance, in October 2018, Spa Track launched a new Auto-Scanner RFID Surgical Instrument. It is a hetero-directional, rotating processing system that takes only 12 seconds for screening a complete instrument plate and can be inaccurate monitoring of every single registration number of items. Such technological advancements are expected to encourage the growth of the global surgical instrument tracking system market during the forecast period

Segmentation

Global Surgical Instrument Tracking System Market has been divided based on Components, Technology, and End-Use.

The market, based on components, has been segmented into hardware, software, and services. The hardware segment accounted for a significant market share of 51.6% in 2019. This large share can be attributed to its growing technological advancements, which is driving the adoption of these devices for inventory management. The hardware segment is further divided into readers, tags, and others.

The market, based on technology, has been bifurcated into barcode tracking and radio frequency identification. The Barcode tracking segment dominated the global surgical instrument tracking system market in 2019. Owing to the low cost of installation has resulted in the increased adoption of barcode technology in the surgical instrument tracking systems market. It held a market share of 86.9% in 2019.

On the basis of end use, the global surgical instrument tracking system market has been classified as hospitals and others. The hospitals segment dominated the global surgical instrument tracking system market in 2019. The large share of 83.0% of hospitals is attributable to the need to cut healthcare expenditure and manage existing instruments for tracking solutions.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/surgical-instrument-tracking-system-market-1391 

Orphan diseases Market – Insights on Upcoming Trends 2027

 Global orphan diseases market also known as rare disease is growing rapidly. It affects a very small percentage of the global population. Most of the orphan diseases are genetic and is remains throughout the life of the patient. There are no exact number of diseases available but approximately there are about 7000 different rare diseases and disorders throughout the globe. Global orphan diseases market is expected to grow at the average CAGR of 24.9% constantly throughout this period 2015-2022. It is also expected that this market which was US$ 121.6 billion in 2015 will grow to US$ 576.9 billion by 2022.However due to lack of awareness, correct diagnosis, correct treatments and availability of healthcare facilities are inhibiting the growth of the global orphan diseases market.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/2547 

Segments:     

Global orphan diseases market has been segmented on the basis of types of diseases which includes autoimmune disorders, genetic disorders, blood disorders, cancer, growth disorder, cardiovascular diseases, neurological disorders, respiratory disorders, digestive disorders, eye disorders and others. On the basis of treatment type it segmented into gene therapy, cell therapy, drug therapy and others. On the basis of end user the market is segmented into hospital and clinics, research laboratory and others.

Regional Analysis of Global Orphan diseases Market:  

Considering the global scenario of this market, North American region is believed to be the largest market of the global orphan diseases market. Moreover the European market is also growing and is the second largest market for global orphan diseases. On the other hand, Asia-Pacific’s orphan disease market is expected to grow at a significant rate during the forecasted period. Rest of the World is likely to have a limited but steady growth with respect to this market.

Key Players for Global Orphan diseases Market:  

Some of the key players in this market are: Bristol-Myers Squibb Company (US), Novartis AG (Switzerland), CELGENE CORPORATION (US), F. Hoffmann-La Roche Ltd (Switzerland), Pfizer Inc. (US), Alexion (US), Sanofi (French), Vertex Pharmaceuticals Incorporated (US), GlaxoSmithKline plc. (UK), Merck & Co., Inc (US), AbbVie Inc. (US)

The report of global orphan diseases market by Market Research Future comprises of extensive primary research along with the detail analysis of qualitative as well as quantitative aspects by various industry experts and key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by  top key players in the industry. The report also gives a broad study of different markets segments and regions.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/orphan-diseases-market-2547